Cargando...
Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
BACKGROUND/AIMS: Programmed death-ligand 1 (PD-L1) expression, a validated predictive biomarker for anti-PD-1/PD-L1 inhibitors, is reported to change over time. This poses challenges during clinical application in non-small cell lung cancer. METHODS: This study included patients with non-small cell...
Guardado en:
| Publicado en: | Korean J Intern Med |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Korean Association of Internal Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8273838/ https://ncbi.nlm.nih.gov/pubmed/32872743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2020.178 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|